#Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer | New England Journal of Medicine www.nejm.org/doi/full/10....
nejm.org
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer | NEJM
Current therapies offer limited benefit for patients with previously treated metastatic
pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is
the key driver of PDAC, w...